Sonja C. Henzen‐Logmans

2.9k citations

26 papers · 2.2k indexed · 1 hit paper · h-index 19

Cancer Research top 5%
- Protease and Inhibitor Mechanisms 3
Genetics top 5%
Pathology and Forensic Medicine top 5%
- Breast Lesions and Carcinomas 3
Oncology top 5%
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 3
Dermatology
- Cancer and Skin Lesions 3
Cellular and Molecular Neuroscience
- Neuroscience and Neuropharmacology Research 2
Molecular Biology
- TGF-β signaling in diseases 2

Co-authors: Jan G.M. Klijn Bert van Geel Martinus F. Niermeijer Marian B. E. Menke‐Pluymers Ans M.W. van den Ouweland Carina C. M. Bartels Caroline Seynaeve Cecile T.M. Brekelmans
Cited by: Cancer Research Genetics Pathology and Forensic Medicine
Partner nations: Netherlands Germany France

In The Last Decade

Sonja C. Henzen‐Logmans

25 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2001 Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation

Peers

Countries citing papers authored by Sonja C. Henzen‐Logmans

Since Specialization

Citations

This map shows the geographic impact of Sonja C. Henzen‐Logmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja C. Henzen‐Logmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja C. Henzen‐Logmans more than expected).

Fields of papers citing papers by Sonja C. Henzen‐Logmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja C. Henzen‐Logmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja C. Henzen‐Logmans. The network helps show where Sonja C. Henzen‐Logmans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sonja C. Henzen‐Logmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sonja C. Henzen‐Logmans Line = papers co-authored together Sonja C. Henzen‐Logmans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutationbreakdown → Hanne Meijers-Heijboer,Bert van Geel,Wim L.J. van Putten,Sonja C. Henzen‐Logmans,Caroline Seynaeve,Marian B. E. Menke‐Pluymers,Carina C. M. Bartels,Leon C. Verhoog,Ans M.W. van den Ouweland,Martinus F. Niermeijer,Cecile T.M. Brekelmans,Jan G.M. Klijn	2001	658
2	Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy Augustinus D. G. Krol,Henriëtte W.A Berenschot,Dew Doekharan,Sonja C. Henzen‐Logmans,Bronno van der Holt,Mars B. van ’t Veer	2001	15
3	Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor Peter Sillevis Smitt,Ayae Kinoshita,B. de Leeuw,Wiebe Moll,Michiel Coesmans,Dick Jaarsma,Sonja C. Henzen‐Logmans,Charles J. Vecht,Chris I. De Zeeuw,Naohiro Sekiyama,Shigetada Nakanishi,Ryuichi Shigemoto	2000	309
4	Cytokine‐regulated urokinase‐type‐plasminogen‐activator (uPA) production by human breast fibroblasts in vitro Anieta M. Sieuwerts,Jan G.M. Klijn,Sonja C. Henzen‐Logmans,John A. Foekens	1999	34
5	Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast Vibeke Kuenen‐Boumeester,Sonja C. Henzen‐Logmans,Mieke M. Timmermans,Iris L. van Staveren,Albertus van Geel,Hans J. Peeterse,J. Bonnema,Els M.J.J. Berns	1999	37
6	Prognostic value of CD44 variant expression in primary breast cancer John A. Foekens,Peter Dall,Jan G.M. Klijn,Petra Skroch-Angel,Cassandra J.C. Claassen,Maxime P. Look,Helmut Ponta,Wim L.J. van Putten,Peter Herrlich,Sonja C. Henzen‐Logmans	1999	48
7	High prevalence of codon 213ARG→STOP mutations of theTP53 gene in human ovarian cancer in the southwestern part of The Netherlands Monique Schuyer,Sonja C. Henzen‐Logmans,Maria E.L. van der Burg,Elly Fieret,Jan G. M. Klijn,John A. Foekens,Els M.J.J. Berns	1998	13
8	Urokinase-type-plasminogen-activator(UPA) production by human breast (myo)fibroblastsin vitro: Influence of transforming growth factor-β1 (TGFβ1) compared with factor(s) released by human epithelial-carcinoma cells Anieta M. Sieuwerts,Jan G.M. Klijn,Sonja C. Henzen‐Logmans,Ivo Bouwman,Kees E. P. van Roozendaal,Harry A. Peters,Buddy Setyono-Han,John A. Foekens	1998	30
9	Ultrasound‐Guided Aspiration Biopsy for Detection of Nonpalpable Axillary Node Metastases in Breast Cancer Patients: New Diagnostic Method J. Bonnema,A.N. van Geel,B van Ooijen,S.P.M. Mali,S.L. Tjiam,Sonja C. Henzen‐Logmans,Paul Schmitz,Theo Wiggers	1997	191
10	Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources Kees E. P. van Roozendaal,Jan G.M. Klijn,B van Ooijen,C. Claassen,Alexander M.M. Eggermont,Sonja C. Henzen‐Logmans,John A. Foekens	1996	53
11	Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors Maria E.L. van der Burg,Sonja C. Henzen‐Logmans,Els M.J.J. Berns,Wim L.J. van Putten,Jan G.M. Klijn,John A. Foekens	1996	55
12	Quality Control of Immunocytochemical Staining of Effusions Using a Standardized Method of Cell Processing Vibeke Kuenen‐Boumeester,Petri van Loenen,Elly M.C.A. de Bruijn,Sonja C. Henzen‐Logmans	1996	29
13	Ki‐67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: Correlation with steroid receptors, epidermal‐growth‐factor receptor and cathepsin D Sonja C. Henzen‐Logmans,Elly Fieret,Els M.J.J. Berns,Maria E.L. van der Burg,Jan G.M. Klijn,John A. Foekens	1994	23
14	Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication Wim H.J. Kruit,K. Punt,S.H. Goey,P H de Mulder,D C van Hoogenhuyze,Sonja C. Henzen‐Logmans,G. Stoter	1994	40
15	The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study Maria W.L. van der Burg,Sonja C. Henzen‐Logmans,John A. Foekens,Els M.J.J. Berns,C. J. Rodenburg,Wim L.J. van Putten,Jan G.M. Klijn	1993	33
16	Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: Three case reports and a review of the literature Arendjan Wijnmaalen,B van Ooijen,Bert N. van Geel,Sonja C. Henzen‐Logmans,A. D. Treurniet-Donker	1993	76
17	Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer Els M.J.J. Berns,Jan G. M. Klijn,Sonja C. Henzen‐Logmans,C. J. Rodenburg,Maria E.L. van der Burg,John A. Foekens	1992	47
18	Toxic dermatitis induced by 10-ethyl-10-deazaaminopterin (10-EdAM), a novel antifolate Jaap Verweij,Jan H. Schornagel,Pieter De Mulder,Sonja C. Henzen‐Logmans,F. Cognetti,Michel Clavel,Jan B. Vermorken	1990	10
19	Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients Johannes C. Nossent,Sonja C. Henzen‐Logmans,Thea M. Vroom,Jo H. M. Berden,Tom J. G. Swaak	1990	120
20	Phase I studies of rodorubicin single bolus and daily times five, once every three weeks in patients with advanced solid tumors Jaap Verweij,Maria E.L. van der Burg,W L van Putten,Sonja C. Henzen‐Logmans,E. Salewski,H. P. Kraemer,G. Stoter	1989	0

About Sonja C. Henzen‐Logmans

Sonja C. Henzen‐Logmans is a scholar working on Cancer Research, Dermatology and Oncology, having authored 26 papers that have together received 2.2k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (3 papers), Cancer and Skin Lesions (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Protease and Inhibitor Mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related Molecular Pathways (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and TGF-β signaling in diseases (2 papers). The work is most often cited by research in Cancer Research (596 citations), Genetics (702 citations) and Pathology and Forensic Medicine (438 citations). Sonja C. Henzen‐Logmans has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Jan G.M. Klijn, Bert van Geel, Martinus F. Niermeijer, Marian B. E. Menke‐Pluymers, Ans M.W. van den Ouweland, Carina C. M. Bartels, Caroline Seynaeve, Cecile T.M. Brekelmans, Leon C. Verhoog and Vibeke Kuenen‐Boumeester.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact